Form 4: Rocket Pharmaceuticals Executive Exercises Options and Sells Shares
SEC Form 4
John Militello, VP and Principal Accounting Officer of Rocket Pharmaceuticals, exercised stock options and sold 10,000 shares of common stock on February 29, 2024.
Summary
- On February 29, 2024, John Militello, VP and Principal Accounting Officer and Interim Principal Financial Officer of Rocket Pharmaceuticals, exercised stock options to acquire 10,000 shares of common stock at a price of $12.55 per share.
- Simultaneously, Militello sold 10,000 shares of common stock at a weighted average price of $29.845, with individual sales ranging from $29.78 to $29.91.
- Following these transactions, Militello directly owns 21,517 shares of Rocket Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. An executive exercising options and selling shares is a common occurrence and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives, which can be of interest to investors.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine insider transaction.
Key Dates
| Date | Description |
|---|---|
| 01/08/2019 | One-third of the stock options became fully vested and exercisable. |
| 02/29/2024 | John Militello exercised stock options and sold shares. |
| 03/04/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.